Information Provided By:
Fly News Breaks for October 20, 2016
RMD
Oct 20, 2016 | 07:09 EDT
Jefferies analyst Anthony Petrone says his firm's follow-up survey of U.S.-based durable medical equipment providers shows that pricing is worse than expected. 76% of respondents are seeking an average 14% price discount while 72% will sell an equal amount of more of Philips new Dream versus ResMed's AirSense10 over next 12 months, Petrone tells investors in a research note. The analyst views the findings as negative for ResMed and keeps an Underperform rating on the shares with a $58 price target.
News For RMD From the Last 2 Days
There are no results for your query RMD